Trio Resources Becomes Part of Consortium to Research Arsenic Use in Solar Panels

Trio Resources, Inc. has joined a consortium that is researching ways to take arsenic, a waste product commonly found in mines across Canada, and use it in the production of solar panels.

Trio will work with scientists in Europe and North America to develop a replacement for the silicon in photovoltaic cells with Gallium arsenide ("GaAs"). The Company will contribute to the consortium by developing environmental improvements to capture arsenic from its ore bodies that can be used in the development of the GaAs.

Shortcomings in silicon-based technologies have prompted researchers to study alternative semiconductors that could provide faster and lower power devices. GaAs, a compound made from gallium and arsenic, offers a series of advantages over current technology, including requiring less voltage to enter saturation, providing better photo response and electron mobility and generating a wider operating temperature.

Duncan Reid, CEO of Trio Resources, Inc., commented: "We are excited to be a part of this innovative project, which seeks to take arsenic, a potentially hazardous material commonly found in tailings ponds, and develop it into a useful product that could contribute to the proliferation of clean energy. Our decision to join the consortium reflects our commitment to finding innovative ways to monetize our Duncan-Kerr Property. We look forward to providing updates as this exciting research unfolds while continuing to seek new ways to maximize shareholder value."

Source: http://www.trioresources.com

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.